Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting vs. zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis (RESTENT-ISR trial).

@article{Hong2016ProspectiveRC,
  title={Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting vs. zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis (RESTENT-ISR trial).},
  author={Soon Jun Hong and Chul Min Ahn and Byeong Keuk Kim and Young Guk Ko and S B Hur and Cheol Woong Yu and Seung-Jin Lee and Cheol Ung Choi and Je Sang Kim and Jung-han Yoon and Young Joon Hong and J. Choi and Seung Hyuk Choi and Yangsoo Jang and Do Sun Lim},
  journal={European heart journal},
  year={2016},
  volume={37 45},
  pages={
          3409-3418
        }
}
AIMS At present no proven standard treatment for drug-eluting stent (DES) restenosis is available, and the efficacy and safety of everolimus-eluting stent (EES) and zotarolimus-eluting stent (ZES) for DES restenosis are limited. The purpose of this prospective, randomized 9-month intracoronary ultrasound (IVUS) and 3-year clinical follow-up study was to compare the effects of EESs and ZESs on neointima volume and major adverse cardiovascular events (MACEs) such as death, myocardial infarction… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Similar Papers

Loading similar papers…